Butopamine
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391701This classification denotes a beta-adrenergic agonist with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZX7907IE2H, chemically known as benzenemethanol, 4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-, (r-(r*,r*)) but generally known as butopamine, which bears US NIH Compound Identifier 68556. European Medicines Agency schedules Butopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06031MIG. The term BUTOPAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). BUTOPAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butopamine under HS 29225000 and SITC 51467. As of Q4 2014, BUTOPAMINE remains the US FDA Preferred Term for this commodity. Butopamine bears US NLM identifiers UMLS ID C0054265 and NCI Concept Code C81649. SMILES: OC(CNC(CCC1CCC(O)CC1)C)C1CCC(O)CC1.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.